Registration closes on December 17, 2021. Together, we made great strides in 2020 on Capitol Hill, and we are excited to announce that we now have more OCRA Advocate Leaders than ever before speaking up for the ovarian cancer community. With more than 120 individuals selected—including 53 returning participants—our Advocate Leader program has more than … Continued
We’re probably all ready to say goodbye to 2020, if we have to be honest with ourselves. And yet, we can’t look back and say that the year was entirely bad. With your support, OCRA actually accomplished quite a lot and we have much for which to feel hopeful. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS WAYS TO GIVE … Continued
Urge your U.S. Senators to restore full funding for ovarian cancer research The Ovarian Cancer Research Program (OCRP) housed within the Department of Defense is the federal government’s only program dedicated entirely to ovarian cancer research. Yet, funding for it is in serious jeopardy of being slashed by more than two-thirds. Though the House passed legislation … Continued
We’re full on into fall, and giving thanks for all that we’ve accomplished together, in a year that’s been more than a little challenging. RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS EVENTS WAYS TO GIVE
I never say, ‘I have cancer,’ because it’s not mine. I’m dealing with it. Elle Simone In the same way that a complex dish is made up of distinct ingredients that blend together and bring out new flavors, Elle Simone’s life resembles something that could only come out of a Michelin-rated restaurant. Elle is really … Continued
Be a voice for the ovarian cancer community. Please note: The deadline for application was December 7, 2020. Sign up for email alerts to stay updated on opportunities to take action! Apply today to join survivors, caregivers and activists from across the country using their voices to affect change for those touched by ovarian cancer. As … Continued
The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions of people with pre-existing conditions, including ovarian cancer. OCRA is vigilantly monitoring this upcoming decision, and preparing strategies for addressing any outcomes that may threaten … Continued
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA listening session in the video below.
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve learned so much and strengthened our community. Here are just some of the ways: RESEARCH ADVOCACY PATIENT SUPPORT & PROGRAMS OCRA HEROES EVENTS WAYS TO … Continued
US Representative Rosa DeLauro (D-CT) is the Chair and founder of the Congressional Ovarian Cancer Caucus. Established in 2015, the Caucus set out to raise awareness of ovarian cancer symptoms and support for research. This was almost a decade after Representative DeLauro helped lead a bipartisan coalition to pass the original Johanna’s Law – also … Continued
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law. What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, the legislation supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and … Continued
With 1 in 78 diagnosed with ovarian cancer—and no early detection test for the disease—it is crucial that we spread the word so others can be knowledgeable about the symptoms and risk factors. We need YOUR help to share the facts this Ovarian Cancer Awareness Month! Below are graphics and sample language for you to … Continued
Get email updates about research news, action alerts, and ways to join the fight.
